Vimentin (J144) Antibody sc-53464 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemVimentin (J144) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-53464
Antibody TypePrimary Antibodies
Quantity200 µg/ml
CloneJ144
ApplicationsWB, IP, IF, IHC(P)
Reactivitymouse, rat, human
FormatPurified
Hostmouse
Conjugate/TagUnconjugated
ClonalityMonoclonal
NCBI Full Gene Namevimentin
IsotypeIgM
TargetVimentin

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancerBiochemical PharmacologyOctober 1, 2024Caiming Xu, Silvia Pascual-Sabater, Cristina Fillat, Ajay GoelCell Signaling Technology (Boston, MA, USA). Antibodies against ZEB1 (sc-515797), E-cadherin (sc-21791), and Vimentin (sc-53464) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against LAMB3 (26795-1-AP)

(2) Experimental Correction and Treatment of Chronic Liver Failure Using Implantable Cell-Engineering Constructs of the Auxiliary Liver Based on a Bioactive Heterogeneous Biopolymer HydrogelGels (Basel, Switzerland)June 1, 2023Shagidulin M, Onishchenko N, Sevastianov V, Krasheninnikov M, Lyundup A, Nikolskaya A, Kryzhanovskaya A, Voznesenskaia S, Gorelova M, Perova N, et al.

(3) β1-Integrin plays a major role in resveratrol-mediated anti-invasion effects in the CRC microenvironmentFrontiers in pharmacologyJanuary 1, 2022Brockmueller A, Mueller AL, Shayan P, Shakibaei M.from Sigma-Aldrich (Taufkirchen, Germany). Monoclonal anti-E-cadherin (#sc-21791), anti-vimentin (#sc-53464), anti-slug (#sc-166476), anti-paxillin (#sc-365059) normal mouse IgG (#sc-2025) were from Santa Cruz Biotechnology

(4) Melatonin suppresses epithelial‑to‑mesenchymal transition in the MG‑63 cell lineMolecular medicine reportsMarch 1, 2020Chen Y, Zhang T, Liu X, Li Z, Zhou D, Xu W.(cat. no. sc‑13520), E‑cadherin (cat. no. sc‑52327), N‑cadherin (cat. no. sc‑8424), vimentin (cat. no. sc‑53464), Snail (cat. no. sc‑10437), β ‑actin (cat. no. sc‑69879) and HIF‑1α (cat. no. sc‑53546) were purchased from

(5) SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancerEndocrine-related cancerFebruary 1, 2020Han F, Liu W, Li J, Zhang M, Yang J, Zhang X, Hao X, Yin L, Mao C, Jiang X, et al.

(6) SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancerEndocrine-related cancerMarch 1, 2019Han F, Liu WB, Li JJ, Zhang MQ, Yang JT, Zhang X, Hao XL, Yin L, Mao CY, Jiang X, et al.sc-59987), FIBRONECTIN/FN1 (1:150, Bioss, bs-0666R) and VIM antibody (1:200; Santa Cruz Biotechnology; sc-53464). The IHC staining was quantified as described in Supplementary data. SOX30 expression was categorized

(7) 2-aminopurine suppresses the TGF-β1-induced epithelial-mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosisCell death discoveryDecember 1, 2018Weng D, Chen JX, Li HH, Liu F, Zhou LD, Liu HP, Zheng RJ, Jiang Y, Liu ZH, Ge B.

(8) Granular cell tumor mimicking a squamous cell carcinoma of the tongue: a case reportBMC research notesJanuary 3, 2017Ferreira JC, Oton-Leite AF, Guidi R, Mendonça EF.

(9) MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder CancerCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2017He M, Zhan M, Chen W, Xu S, Long M, Shen H, Shi Y, Liu Q, Mohan M, Wang J.Cell Signaling Technology), TWIST1 (1:500, sc-6070, Santa Cruz), β-catenin (1:500, sc7963, Santa Cruz), Vimentin (1:1000, sc-53464, Santa Cruz), E-cadherin (1:500, SAB4503751, Sigma), Ki67 (1:1000, No.9449, Cell Signaling Technology),

(10) miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1International journal of oncologyJuly 1, 2016Hu J, Shan Z, Hu K, Ren F, Zhang W, Han M, Li Y, Feng K, Lei L, Feng Y.nonfat milk and then incubated overnight at 4˚C with primary antibodies (Sp1, sc-420, 1:300; Vimentin, sc-53464, 1:200; Fibronectin, sc-81769, 1:400; N-cadherin, sc-393933, 1:600; E-cadherin, sc-21791, Β actin, sc-130300,

(11) MicroRNA‑143 targets CD44 to inhibit breast cancer progression and stem cell-like propertiesMolecular medicine reportsJune 1, 2016Yang Z, Chen D, Nie J, Zhou S, Wang J, Tang Q, Yang X.E-cadherin antibody (67A4; cat. no. sc-21791; dilution, 1:1,000) and vimentin antibody (J144; cat. no. sc-53464; dilution, 1:1,000) (all from Santa Cruz Biotechnology, Inc) as well as anti-αSMA (1A4; dilution, 1:2,000;

(12) TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signalingCellular and molecular life sciences : CMLSMay 1, 2016He K, Guo X, Liu Y, Li J, Hu Y, Wang D, Song J.

(13) SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinomaTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineMarch 1, 2016Yu Y, Chen Y, Ma J, Yu X, Yu G, Li Z.

(14) Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosisScientific reportsFebruary 15, 2016Hammam OA, Elkhafif N, Attia YM, Mansour MT, Elmazar MM, Abdelsalam RM, Kenawy SA, El-Khatib AS.MN, USA), alpha smooth muscle actin (α-SMA) (Cat. No. M0851, Dako, CA, USA), and vimentin (Cat. No. sc-53464, Santa Cruz Biotechnology, CA, USA) diluted at 1:100, in PBS. We used a streptavidin-biotin-peroxidase

(15) YiQi ChuTan Recipe Inhibits Epithelial Mesenchymal Transition of A549 Cells under HypoxiaCellular and molecular biology (Noisy-le-Grand, France)January 11, 2016Chen CM, Sun LL, Fang RM, Lin LZ.

(16) Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancerBiochemical pharmacologyNovember 1, 2015Buhrmann C, Shayan P, Kraehe P, Popper B, Goel A, Shakibaei M.

(17) Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancerMolecular carcinogenesisOctober 1, 2015Nagaraju GP, Long TE, Park W, Landry JC, Taliaferro-Smith L, Farris AB, Diaz R, El-Rayes BF.

(18) Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapyMolecular medicine reportsMay 1, 2015Jiang H, Wang H, Wang S, Pei Z, Fu Z, Fang C, Wang J, Lu Q, Wang E, Li J.

(19) Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transitionWorld journal of gastroenterologyJanuary 14, 2015Hou KZ, Fu ZQ, Gong H.Santa Cruz Biotechnologies Inc., Dallas, TX, United States: anti-E-cadherin (sc-21791), anti-vimentin (sc-53464), anti-AKT (sc-5298), antiphospho(p)-AKT (sc-33437), anti-β-catenin (sc-7963) and anti-GAPDH (sc-25778). MATERIALS

(20) MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumorTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineSeptember 1, 2014Liu S, Cui J, Liao G, Zhang Y, Ye K, Lu T, Qi J, Wan G.

Be the First to Write a Review!

Vimentin (J144) Antibody

Vimentin (J144) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (31)

Reviews

Vimentin (J144) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map